Intellia Therapeutics (NTLA) Q4 2024 Earnings

7NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-1.52
-1.39
-1.25
-1.12

Details

Expected EPS
-1.39013
Actual EPS
-1.34
Surprise EPS
0.05
Surprise Percent
+3.61%

Description

Intellia Therapeutics (NTLA) has reported earnings of -1.34 per share for Q4 2024.

0 Comments

Share your thoughts